My product: Sucralose Sclareolide ,Sclareol,Clary Sage oil,Rhizoma Polygoni Cuspidati PE. Introduction,
Resveratrol.Silybin,Milk Thistle PE., Silymarin,Milk Thistle PE,Podophyllotoxin,Artesunate,Artemether ,
Dihydroartemisinin Dihydro artemisinin,Gold Theragran P.E., Lutein, Sucralose
Gynostemma pentaphyllum(Thunb.)Mak
As a tech-driven high-tech enterprise, the company was jointly invested and established by overseas people at high academic level and the North West University. It possesses several senior administrative personnel, a high-level technical research and development team and a domestic first-class management and R&D talents.
The company has rich profession resources and extremely competitive innovation commercial model. Cooperating with the Northwest University, it built a base for production, study and research, which has the advanced complete R&D condition and rich and convenient research resources.
The company concentrates on R&D and the promoting application of the innovative biological medicine technology. It has successfully developed some items including Sclareol and Sclareolide and is applying for the national patent at present. At the meantime, the R&D of the two items -"the combination of biological and chemical processes to synthesize Salvianolic acid B technology" and "highly effective technology of taking Podophyllotoxin as raw material to synthesize anti-cancer medicine VP16, the VM26 ", have also been finished and will enter the market in the near future.
The company takes "innovate apply the advanced life sciences technology and make great efforts to improve public health competence and life quality "as its duty. We consistently, unremittingly trace, apply the latest professional science and technology, and update the quality of products and services, offer best-quality products and better, faster services to customers. It makes great efforts to seek for the mutual development of the relevant party cooperation with an attitude of responsible for staff, customers, shareholders and society.